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Abstract
Background: Despite a growing understanding of the effectiveness of bereavement interventions
and the groups that benefit most from them, we know little about the cost-effectiveness of
bereavement interventions.
Methods: We conducted a cost-utility analysis alongside a randomized clinical trial on a visiting
service for older widowed individuals (n = 110) versus care as usual (CAU; n = 106). The visiting
service is a selective bereavement intervention that offers social support to lonely widows and
widowers by a trained volunteer. Participants were contacted 6–9 months post-loss. Eleven
percent of all contacted persons responded and eight percent participated in the trial. The primary
outcome measure was quality adjusted life years (QALYs) gained (assessed with the EQ-5D), which
is a generic measure of health status. Costs were calculated from a societal perspective excluding
costs arising from productivity losses. Using the bootstrap method, we obtained the incremental
cost utility ratio (ICUR), projected these on a cost-utility plane and presented as an acceptability
curve.
Results: Overall, the experimental group demonstrated slightly better results against slightly
higher costs. Whether the visiting service is acceptable depends on the willingness to pay: at a
willingness to pay equal to zero per QALY gained, the visiting service has a probability of 31% of
being acceptable; beyond €20,000, the visiting service has a probability of 70% of being more
acceptable than CAU.
Conclusion: Selective bereavement interventions like the visiting service will not produce large
benefits from the health economic point of view, when targeted towards the entire population of
all widowed individuals. We recommend that in depth analyses are conducted to identify who
benefits most from this kind of interventions, and in what subgroups the incremental cost-utility is
best. In the future bereavement interventions are then best directed to these groups.
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The death of a spouse can lead to serious psychological
problems [1], although the impact of spousal bereave-
ment on mental health diverges among the widowed. Tar-
geted support can have a preventive effect and reduce
psychological problems resulting from the death of the
spouse [2-5]. However, not all studies on bereavement
interventions demonstrate positive results [6-8]. Bereave-
ment interventions are defined as all interventions devel-
oped to benefit bereaved persons in terms of alleviating
the emotional and practical problems following the loss
of a loved one. Types of intervention can vary from self-
help groups to psychotherapy. It appears that the effec-
tiveness of a bereavement intervention is largely deter-
mined by the population towards it is directed. Most
outreaching preventive interventions for all widowed
individuals are not very beneficial [9], probably because
most of the widowed are able to adjust relatively well over
time and do not need a specific intervention to regain pre-
bereavement levels of functioning. However, this does not
apply to all widowed individuals. Several widowed indi-
viduals are not able to deal with the loss on their own, and
for those widows and widowers a bereavement interven-
tion could be very helpful. Interventions directed towards
widows and widowers with a high risk profile, such as
having more severe psychological problems or symptoms
of complicated grief, do show desirable results [9].
Despite a growing understanding of the effectiveness of
bereavement interventions and the groups that benefit
most from them, we know little about the cost-effective-
ness of bereavement interventions. It is reasonable to
assume that some interventions, especially those provided
by volunteers, could be cost-effective – even when no
superior clinical results could be demonstrated. It is plau-
sible that widows and widowers that have been offered
targeted support by volunteers will make less use of health
care services, the latter being considerably more expensive
than the attention of (trained) volunteers. In order to test
this hypothesis, we conducted a cost-utility analysis
alongside a randomized clinical trial on a visiting service
for older widowed individuals, which failed to demon-
strate superior clinical effects on depression of targeted
support by trained volunteers over care as usual (Onrust,
Willemse, van den Bout & Cuijpers, in press.).
Methods
Sample and setting
This cost utility analysis was based on a randomized con-
trolled study on the effects of a visiting service for older
widowed individuals. The research has been judged and
ethically approved by the METiGG, a medical-ethical
committee for research in mental health care settings in
the Netherlands. The study was conducted in 18 munici-
palities in the Netherlands. Making use of the Registry
Office, letters were sent to all residents at the age of 55 and
older who had lost their spouse 6 – 9 months earlier. This
is consistent with the recruitment procedure of most visit-
ing services in the Netherlands. Respondents were con-
tacted only 6 – 9 months after the loss, because in the
initial stage of bereavement, social support is usually
available in the direct environment of family, friends and
neighbours. The letters contained information about the
study, an informed consent form, and a short screenings
questionnaire. In order to increase study participation, we
used local media to inform the population and stimulate
application. This media attention resulted in several par-
ticipants who had not yet received a letter because the
death was more recent than 6 months, or who had recon-
sidered participation several months after they were con-
tacted. This media attention also resulted in 5 participants
(2,3%) slightly younger than 55 years of age. Since it is
not unconventional that slightly younger individuals
make an appeal to the visiting service, and since age did
not predict the effects of the visiting service (Onrust & Wil-
lemse et al., in press), these respondents were included in
the study.
To be eligible for the study, respondents had to meet the
following inclusion criteria: widowed during the past
year, moderate or strong feelings of loneliness, and the
absence of a full-blown mental disorder. In addition,
respondents had to be capable of participating in a 1-
hour-long interview. Further explanation of the inclusion
criteria is presented elsewhere (Onrust & Willemse et al.,
in press).
Figure 1 presents the several steps of the recruitment of
study participants. During the one year recruitment
period, a total of 2,708 letters were sent to widowed indi-
viduals. In total, 308 widowed individuals (11,4%)
returned the informed consent form. In order to deter-
mine whether the widowed individuals agreeing to partic-
ipate were eligible for the study, we carried out a stepwise
screening procedure.
At first, we measured feelings of loneliness with the 'Lone-
liness Scale' [10], which was enclosed in the request for
participation. Only respondents with at least moderate
feelings of loneliness were included in the study. We
excluded respondents without feelings of loneliness
because the intervention was designed for widowed indi-
viduals with social support deficits and because bereave-
ment interventions directed towards the entire population
of widowed individuals are generally not effective. Of the
308 widowed individuals agreeing to participate, 27 wid-
ows and widowers (8,8%) were excluded because they did
not report feelings of loneliness.Page 2 of 12
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ing interview, in order to ascertain the capability of engag-
ing in a 1-hour-long interview and the absence of a full-
blown mental disorder. The presence or absence of full-
blown mental disorders was measured with the M.I.N.I.
Plus, a short standardized diagnostic interview [11]. A
total of 33 widowed individuals (10,7%) were excluded
from the study, as they were considered to be not capable
of participating, mostly because they were confused and
did not understand the objectives of the study. Based on
the M.I.N.I., another 30 widows and widowers (9,7%)
were excluded as they appeared to meet the DSM-IV diag-
nostic criteria for either depression or an anxiety disorder.
The remaining 218 widowed individuals (71% of those
agreeing to participate; 8,1% of all persons approached)
met inclusion criteria and were approached for the base-
line measurement. This measurement was completed by
216 widowed individuals who were randomly allocated
to the visiting service (n = 110) or a brief brochure (n =
106). The randomization was carried out centrally, using
blocked randomization stratified for gender and region
with the widowed individual as unit of randomization,
with blocks of two widowed individuals. Data were col-
lected at baseline, at 6 months, 12 months and 24 months
Participants flow through the studyFigure 1
Participants flow through the study.Page 3 of 12
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attempted to be scheduled as close as possible to the
intended point in time, we did allow a deviation of (± 2
weeks). This paper focuses on the cost-utility of the visit-
ing service at the 12 months follow-up assessment, as the
intervention was administered during the first 12 months
of the study and potential shifts in health care utilization
were most likely to occur during this period. At the 12
month follow-up assessment 185 (86%) widows and wid-
owers were retained in the trial. The recruitment of partic-
ipants and the baseline measurements took place in
2003–2004, data collection for the 12 month follow-up
assessment was carried out in 2004–2005.
Intervention
The experimental intervention was the visiting service,
based on the Widow-to-Widow program [12]. Respond-
ents who were allocated to the visiting service were offered
10 – 12 home visits by a trained volunteer. During the
home visits, one-to-one support was offered by exchang-
ing experiences and emotions. The volunteers provided
the respondents with the opportunity to express their feel-
ings and a better understanding of their grieving process.
In addition, the volunteers provided information and
sometimes practical help. All volunteers were widowed
themselves for some years. They had attended a course of
6 meetings, in which both theoretical knowledge (grief
phenomena; tasks of grief; loneliness and social support)
and practical skills (empathic listening; conversation tech-
niques; setting boundaries) were learned. Mainly based
on the way they participated in this course, their eligibility
for the program was evaluated. During the period of home
visits, all volunteers were supervised by the coordinator of
the visiting service. The coordinators of all visiting services
had also attended a course of 6 meetings. In this course,
which was based on the "Manual Visiting Services" [13],
information was provided on the organization and proce-
dure of the visiting service and the supervision of the vol-
unteers.
Respondents who were allocated to the visiting service
were allowed to use all other types of health services and
community resources during the intervention period.
The comparison (control) intervention consisted of a
brief brochure on depressive symptoms. The brochure
provided information and several tips to improve well-
being. Respondents who were allocated to the compari-
son group were not offered any type of intervention, but
were allowed to use all types of health services and com-
munity resources with the exception of the visiting service
during the study. Mostly, widowed individuals are sup-
ported by their direct environment. This support generally
diminishes over time. Although there are several interven-
tions available for widowed individuals to cope with their
grief, it depends on the widowed individual whether he or
she will actually use the available services. Generally, only
a small amount of the widowed population does make
use of special services.
Clinical end terms
Quality of life was assessed with the EuroQol (EQ-5D)
[14]. The EuroQol is made up of five dimensions: Mobil-
ity, Self-care, Usual Activities, Pain/Discomfort, and Anxi-
ety/Depression. Respondents were asked to indicate for
each dimension whether they experienced 'no problems',
'some problems', or 'extreme problems'. Subsequently,
the separate scores were combined into the EQ-5D Index,
a health status index. The EQ-5D Index can be linked
directly to empirical values for health status of the general
public, which allows the conversion to utilities [15].
Resource use
For this study we adopted a societal perspective, including
the cost of all types of health care services (direct medical
costs), patient costs such as costs for traveling and parking
(direct non-medical costs) and costs deriving from not
being able to perform domestic tasks. We did not include
costs attributable to productivity loss, since our sample
consisted of older widowed individuals of which only a
small part (14%) was employed at baseline. The number
of widowed individuals that did report absence from work
or reduced efficiency at work (3% at baseline and 1% at
follow-up) was too small to be taken into account. Infor-
mation on the use of health care services and the capabil-
ity of performing domestic tasks was gathered with parts
of the Trimbos and institute of Medical Technology
Assessment Questionnaire on Costs Associated with Psy-
chiatric Illness (TiC-P) [16].
Direct medical and direct non-medical costs are presented
in Table 1. Direct medical costs are treatment costs for sev-
eral formal (e.g. general practitioners, mental health serv-
ices, social work, home care) and informal caregivers
(such as family and friends), which were calculated by
multiplying the number of health service units (e.g. con-
sultations, contacts) by their standard cost price [17].
Since the TiC-P measures health care utilization during
the past 4 weeks, the costs were subsequently converted to
annual costs. We also included the costs of antidepressant,
anxiolytic and hypnotic medication, calculated as the
price per standard daily dose as reported in the Pharma-
ceutical Compass [18], multiplied by the number of pre-
scription days, plus the pharmacist's dispensing costs of
€6,45 per prescription. Since most psychiatric drugs are
prescribed for a period of three month on average, we
added the pharmacist's dispensing costs 4 times in order
to estimate annual costs. Medication use was assessed by
the interviewer, who asked the respondents what kind of
prescription drugs they used. Participants were encour-Page 4 of 12
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the correct name of the drug. At last, costs arising from
being too ill to perform domestic tasks were evaluated at
the price of domestic help at €8,30.
Direct non-medical costs are costs patients had to make by
traveling to health service providers and parking. These
costs were valued at €0,16/km and €2,50/hour parking
time. We also added the costs of patients' time spent in
travel, waiting and treatment at €8,30 [17].
All costs are estimated for the reference year 2003 and are
presented in euros.
Intervention costs
Table 2 represents the cost of the visiting service. Direct
medical costs of the intervention included organizing the
visiting service, training of volunteers, supervision of the
volunteers and the intake by the coordinator of the visit-
ing service (either a paid social worker or a volunteer), the
costs of phone calls to both volunteers and participants
and overhead costs. In order to estimate these costs we
used different sources. First, we calculated the annual
costs per participant based on the financial paragraph of
the annual report of two participating visiting services.
Second, the Manual Visiting Services [13], which was used
to set up the visiting services, did also include an estimate
of annual costs. This estimate was indexed for 2003 in two
ways, by means of a Health Care Index and by means of
the General Index as reported by Statistics Netherlands
[19]. The costs of the coordinator could differ depending
on whether the coordinator is paid or not. A paid social
worker is more expensive than a volunteer. Since both
options were possible, we used examples of both options
in the calculation of the intervention costs. Subsequently,
we averaged the four different estimates and added time
costs for the volunteers valued at €12,45 per visit (visit
plus travel time). Together these direct medical costs
Table 1: Direct medical and direct non-medical costs by health service type
Direct Medical Costs (in 2003 €) Direct Non-Medical Costs (in 2003 €)
Health service type unit cost pricea km, P, hrsb cost pricec
Medical doctor Consult 20,20 1.8 km, 1 h 11,10
Medical specialist Consult 98,00 7 km, 2 h 20,20
Regional mental health service Contact 124,00 10 km, 3 h 29,00
Regional addiction serviced Contact 124,00 10 km, 3 h 29,00
Mental Hospital – Outpatient Consult 88,00 12 km, 4 h 37,20
Mental Hospital – Day care Contact 125,00 12 km, 4 h 37,20
Mental Hospital – Inpatient Day 250,00 8 h 66,40
General Hospital – Outpatient Consult 56,00 7 km, 3 h 28,50
General Hospital – Day care Contact 229,00 7 km, 4 h 36.80
Teaching Hospital – Outpatient Consult 100,00 12 km, 3 h 29,30
Academic Hospital – Day care Contact 229,00 12 km, 4 h 37,60
Private practice psychotherapist Session 76,00 5 km, 2 h 19,90
Social workere Contact 45,00 7 km, 3 h 28,50
Physiotherapist Contact 22,75 1,8 km, 2 h 19,40
Alternative Healer Contact 8,30 1,8 km, 2 h 19,40
Self-Help Session 0,00 10 km, 3 h 29,00
Home care, nursing Hour 30,70 0 km, 0 h 0,00
Home care, domestic Hour 21,70 0 km, 0 h 0,00
Informal care (family, friends)f Hour 8,30 0 km, 0 h 0,00
a Integral unit cost prices [17].
b Based on average distances (in km), parking costs and travel + waiting + treatment
times (in hrs) for receiving treatment [17]
c Costs of 1 km = € 0.16, 1 h parking = €2.50 €, 1 h patient's time = €8.30 [17].
d Valued as outpatient mental health services.
e From DFL 77,00 in 1993, converted into Euro, indexed for 2003 (cf. http://www.cbs.nl) and
rounded.
f Valued as domestic help [17].Page 5 of 12
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service. Direct non-medical costs were time costs of the
participant, valued at €8,30/visit.
Analyses
Statistical analysis was guided by some characteristics of
our data.
Primarily, our data were not complete. At the 12 month
follow-up assessment 14.4% of the data was missing. All
analyses were conducted according to the intention-to-
treat principle. Therefore, all missing values were
imputed. In order to replace the missing values by plausi-
ble estimates, we used the regression imputation proce-
dure as implemented in Stata version 9.1 [20].
Secondly, we had to take into account two confounding
variables. Despite random allocation to the research con-
ditions, there were two significant differences between the
experimental group and the control group at baseline.
Participants in the experimental group were on average
more lonely and had a worse quality of life at the start of
the study. We adjusted for both confounders (by using
residualised QALYs), since they were significant predictors
of the QALY end-term,.
In the cost-utility analysis, we calculated the pre-post
changes in costs and the pre-post changes in quality of life
in each of the conditions. Then we calculated the incre-
mental cost-utility ratio (ICUR) across the experimental
and control conditions, which represents the incremental
costs (or savings) per QALY gained in the experimental
condition relative to the control condition. Uncertainty
was assessed by means of non-parametric bootstrapping
(2,500 times) of the data of the individual respondents.
The comparison of the simulated ICURs is presented in a
cost-utility plane (Figure 2), with differences in costs on
the vertical axis and differences in QALYs on the horizon-
tal axis. If the majority of the estimates appear in the top
left-hand quadrant of the plane, the intervention results in
a loss of quality of life against additional costs as com-
pared with the control condition, which makes the inter-
vention clearly unacceptable from a cost-effectiveness
perspective. If the majority of the bootstrapped ICURs
appear in lower right-hand quadrant of the plane, the
intervention produces more QALYs for less costs than the
control condition, which makes the intervention clearly
superior from a cost-effectiveness perspective. In the other
two quadrants the additional costs or savings have to be
weighted against a loss or gain in QALYs.
The results of the cost-utility analysis are also presented in
a cost-utility acceptability curve (Figure 3). The acceptabil-
ity curve represents the probability that the intervention is
cost-effective, given a varying threshold for the willingness
to pay for each QALY gained. Finally, we calculated the
Net Monetary Benefit (NMB) for two different ceilings of
willingness to pay that are usually applied in the Nether-
lands (20,000 euro and 80,000 euro). The net monetary
benefit of a participant is calculated as: net benefit = [(will-
ingness to pay) * Δ effects] – Δ costs.
Sensitivity analyses
As already mentioned, we conducted our main analyses
without the costs attributable to productivity losses since
the majority of our sample was not employed. However,
since productivity loss is usually the main cost-driver, we
repeated all analyses including the costs attributable to
productivity losses. Information on the productivity loss
was gathered with parts of the Trimbos and institute of
Medical Technology Assessment Questionnaire on Costs
Associated with Psychiatric Illness (TiC-P) [16]. To evalu-
Table 2: Calculation of intervention costs
Source Total Costs Period Participants Annual costs per participant
Visiting Service 1 12,808 36 months 20 213
Visiting Service 2 54,900 24 months 80 343
Manual method 1a 3,403 12 months 10 340
Manual method 2b 3,200 12 months 10 320
Mean Intervention 304
Time Costs Volunteers 12.45/visit 12 months 149
Direct Medical Costs 453
Time Costs Participant 8.30/visit 12 months 100
Total Costs Intervention 553
a From DFL 6,000 in 1997, converted into Euro, indexed for 2003 based on Health Care
Index (cf. http://www.cbs.nl) and rounded.
b From DFL 6,000 in 1997, converted into Euro, indexed for 2003 based on General
Index (cf. http://www.cbs.nl) and rounded.Page 6 of 12
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friction-costs obtained from Oostenbrink et al. (2004).
Friction costs represent the monetary counter-value of
production losses that occur during absence from work
with a limit to five months [21]. Second, production
losses also occur when people are ill, try to work, and are
then less efficient. We estimated the number of work cut-
back days as the number of days actually worked when ill,
multiplied by a self-reported inefficiency score, which
ranges between 0 and 1 (0 = as efficient as when in good
health, 1 = totally inefficient). Again, we used friction
costs to valuate these production losses.
Results
Sample
The sample consisted of 138 widows (63.8%) and 78 wid-
owers (36.2%). The age of the participants ranged from 50
to 92 years (Mean = 68.8; Sd = 9.3) and the participants
had received 13 years of education on average. Duration
of widowhood varied from 2 to 14 months (Mean = 7.9;
Sd = 1,9). As already mentioned, participants in the visit-
ing service group differed significantly from participants
in the control group on two variables: participants in the
visiting service group reported more feelings of loneliness
than in the CAU group (Mean = 7.1; Sd = 3.0 versus mean
= 6.0; Sd = 2.9; t = -2.66; p = 0.008) and a worse health-
related quality of life at baseline (EQ-5D utility score
mean = 0.76; Sd = 0,25 versus mean = 0.83; Sd = 0.18; t =
2.19; p = 0.030). There was no significant difference in
loss to follow-up rates between the research conditions.
Furthermore, completers did not differ from non-compl-
eters on any of the baseline variables, which indicated that
loss to follow-up was at random.
Quality of Life
Participants in the visiting service group demonstrated a
significant improvement in health-related quality of life
(EQ-5D utility score at baseline mean = 0.76 (s.d. = 0,25);
EQ-5D utility score at 12 months follow-up mean = 0.80
(s.d. = 0.18); Difference mean = 0.04 (s.d = 0.02) QALY
gained; t = -2.273; p = 0.025). Participants in the control
group did not (baseline mean = 0.83 (s.d. = 0,18); follow-
up mean = 0.81 (s.d = 0.21); Difference mean = 0.01 (s.d.
= 0.02) QALY lost; t= 0.696; p = 0.488). However, the vis-
iting service group did not significantly differ from the
control group in their changes in health-related quality of
life over time when we adjusted for both confounding var-
iables (t = 1.29; p = 0.215).
Cost-effectiveness plane: each dot (n = 2,500) represents a bootstrapped cost-utility ratioFigur  2
Cost-effectiveness plane: each dot (n = 2,500) represents a bootstrapped cost-utility ratio.Page 7 of 12
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Table 3 presents the annual capita costs of both the visit-
ing service group and the control group at baseline and at
the 12 months follow-up assessment. In both groups costs
increased over time, however these changes in costs were
not statistically significant (p = 0.166 in the visiting serv-
ice group and p = 0.430 in the control group). In the vis-
iting service group, the increased costs included the costs
of the intervention (€ 553), but these additional costs
were partly compensated for by savings elsewhere in the
healthcare and welfare sector. The mean difference of the
additional costs was € 210 (s.e. = 363) in favour of the
control group, but this difference was not statistically sig-
nificant (t = -0.579; p = 0.563).
Cost-utility
The incremental cost-utility ratio was calculated as
(ΔCostsE - ΔCostsC)/(ΔQALYE - ΔQALYC), where ΔCosts
represents the average additional per capita costs and
ΔQALY represents the number of QALYs gained over time,
controlled for both confounding variables, in both the
visiting service group (E) and the control group (C). Sub-
stitution yields a cost-utility ratio of (390 - 180)/(0.01 - (-
0.02)) = 6,827. This means that for each QALY gained by
offering the visiting service, the additional costs amount
to € 6,827. Bootstrapping of the data of the individual
respondents yields a median ICUR of € 4,123 (95% Con-
fidence Interval : – €627,530 – €668,056).
The incremental cost-utility ratio is surrounded by a cer-
tain amount of uncertainty, which is presented in the cost-
effectiveness plane (Figure 2). Each dot of the cost-effec-
tiveness plane represents a bootstrap replication (n =
2,500) of the incremental cost-utility ratio; 28% of the
dots are in the lower right-hand quadrant, indicating a
28% probability that the visiting services generates better
health effects against lower costs; there is a 5% probability
that the visiting service generates worse outcomes against
higher costs and a 1% probability that the visiting service
generates worse outcomes against lower costs. However,
most dots (59%) are in the upper right-hand quadrant,
indicating better outcomes against higher costs.
Acceptability
The acceptability curve for the incremental cost-utility
ratio is presented in Figure 3. The visiting service had a
probability of 31% of being more acceptable than the
comparator condition from a cost-effectiveness point of
view under the conservative scenario that there is no will-
ingness to pay for a gain of one QALY. However, people
are generally willing to pay for a QALY gained. When the
willingness to pay is raised to € 10,000, the visiting service
has a probability of 55% of being cost-effective compared
with the informational brochure. Generally, the willing-
ness to pay for a QALY gained by preventive interventions
is approximately €20,000, and at this threshold the visit-
ing service has a probability of 70% of being more accept-
able than CAU.
ICUR acceptability curve: probability cost-utility ratio is acceptable given varying thresholds for willingness to payFigure 3
ICUR acceptability curve: probability cost-utility ratio is acceptable given varying thresholds for willingness to 
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Given a willingness to pay of 20,000 Euro for a QALY
gained, the Net Monetary Benefit is: NMB = 20,000 *
0.031 – 210 = 410. Given a willingness to pay of 80,000
Euro for a QALY gained the Net Monetary Benefit is: NMB
= 80,000 * 0.031 – 210 = 2270.
Sensitivity analyses
When the indirect costs related to the production losses
are included, the incremental cost-utility ratio is €11.239.
Bootstrapping of the data yields a median ICUR of €
6,151 (95% Confidence Interval : – €205,706 –
€222,067). The distribution of the bootstrapped ICURs
Table 3: Annual per capita costs by item and condition
Annual per capita costs (Direct Medical and Direct Non-Medical) in €
Experimental Group (n = 110) Control Group (n = 106)
t0 t2 Diff. t0-t2 t0 t2 Diff. t0-t2
Health service type Mean (sd) Mean (sd) Mean (sd) Mean (sd) Mean (sd) Mean (sd)
Medical doctor 255 (328) 245 (342) -11 (420) 199 (328) 265 (393) 66 (426)
Medical specialist 615 (1534) 490 (1091) -125 (1710) 308 (835) 437 (1087) 129 (1100)
Regional mental health service 169 (860) 115 (438) -54 (978) 38 (273) 82 (471) 44 (548)
Regional addiction service 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Mental Hospital – Outpatient 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Mental Hospital – Day care 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Mental Hospital – Inpatient 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
General Hospital – Outpatient 10 (105) 27 (151) 17 (186) 0 (1) 16 (110) 16 (110)
General Hospital – Day care 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Teaching Hospital – Outpatient 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Academic Hospital – Day care 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Private practice psychotherapist 116 (966) 15 (119) -101 (972) 36 (364) 26 (171) -9 (405)
Social worker 62 (268) 46 (227) -16 (334) 54 (291) 42 (186) -12 (326)
Physiotherapist 298 (810) 322 (931) 24 (1007) 370 (1100) 249 (652) -121 (952)
Alternative Healer 10 (59) 18 (139) 8 (152) 7 (70) 27 (100) 20 (102)
Self-Help 0 (0) 47 (298) 47 (298) 10 (82) 40 (198) 30 (217)
Home care, nursing 1169 (2346) 1261 (2460) 92 (1386) 1068 (2076) 1151 (2078) 83 (1383)
Home care, domestic 55 (491) 35 (246) -20 (350) 32 (200) 9 (82) -24 (141)
Informal care (family, friends) 37 (146) 18 (81) -19 (141) 73 (484) 32 (162) -42 (512)
Antidepressants 14 (60) 13 (68) -1 (35) 1 (13) 1 (13) 0 (0)
Anxiolytics 7 (23) 6 (18) -1 (23) 6 (20) 6 (20) 0 (23)
Hypnotics 10 (24) 9 (18) -1 (20) 4 (14) 5 (14) 1 (13)
Total without intervention 2829 (3837)a 2666 (3333)b -163 (2938)d 2209 (2757)a 2389 (2988)b 180 (2346)d
Intervention: Visiting Service 0 (0) 553 (0) 553 (0) 0 (0) 0 (0) 0 (0)
Total with intervention 2829 (3837)a 3220 (3333)c 390 (2938)e 2209 (2757)a 2389 (2988)c 180 (2346)e
a No significant difference between total costs at baseline (t0) in the experimental group and total costs at baseline (t0) in
the control group.
b No significant difference between total costs without the costs of the intervention at 1-year follow-up (t2) in the
experimental group and total costs at 1-year follow-up (t2) in the control group.
c Total costs including the costs of the intervention at 1-year follow-up (t2) in the experimental group differ significantly
from the total costs at 1-year follow-up (t2) in the control group at p < 0.10 (p = 0.055).
d No significant difference between the cost difference (t2 - t0) without the costs of the intervention in the experimental
group and the cost difference (t2 - t0) in the control group.
e No significant difference between the cost difference (t2 - t0) including the costs of the intervention in the experimental
group and the cost difference (t2 - t0) in the control group.Page 9 of 12
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ICURs fall in the upper right-hand quadrant indicating
that better effects are obtained against higher costs, 5%
fall in the upper left-hand quadrant indicating that the vis-
iting service is inferior, 1% fall in the lower left-hand
quadrant indicating that the visiting service has worse
clinical outcomes against lower costs, and 24% of the
bootstrapped ICURs fall in the lower right-hand quad-
rant, implying that the visiting service is dominant,
because it generates better outcomes against lower costs
than the control condition. Under these circumstances,
the visiting service has a probability of 27% of being
acceptable when the willingness to pay equals zero. When
the willingness to pay is increased to € 10,000, and €
20,000, the probability of the visiting service being more
acceptable than the control condition increases to 49%
and 64% respectively.
Discussion
We conducted a cost-utility analysis with health-related
quality of life as clinical end term. Health related quality
of life was measured with the EQ-5D which is a generic
measure of health status. As only one of the five compo-
nents of the EQ-5D has a psychological nature, it is some-
times debated whether the use of this measure is justified
in the evaluation of psychological interventions. We
believe that it is. First of all, if an individual reports
'extreme problems' on the mental health dimension (anx-
iety/depression) of the EQ-5D, without any other prob-
lems, this health status is still evaluated as 0.36954 by the
Dutch general population [15], which represents poor
health. By resolving these 'extreme problems' in mental
health, effective psychological interventions are able to
demonstrate changes in QALYs. Secondly, the use of a
generic measure of health-related quality of life enables us
to compare the all kinds of interventions on their cost-
effectiveness. And although most effective medical proce-
dures usually demonstrate larger improvements in QALYs
than psychological interventions, their costs are usually
much higher as well. Psychological interventions there-
fore do not need to result in large changes in QALYs to be
cost-effective.
In this study we evaluated the cost-effectiveness of a visit-
ing service for older widows and widowers. The visiting
service is a selective preventive intervention. Selective
bereavement interventions are directed towards bereaved
individuals with a high risk profile. Bereaved individuals
with a high risk profile are more likely to experience an
abnormal form of grief. The visiting service focussed on
loneliness as risk factor. Besides selective bereavement
interventions, there are also universal bereavement inter-
ventions and indicated bereavement interventions, which
are respectively directed towards all bereaved persons and
persons who already are experiencing abnormal bereave-
ment. Besides some positive effects of universal preven-
tion for bereaved children, there is hardly any evidence for
the effectiveness of universal bereavement interventions
[9]. Screening for high risk seemed to increase the efficacy
of bereavement interventions. Some studies on selective
bereavement interventions demonstrated modest effects,
although there were some indications that this is only
temporary [9]. Indicated interventions generally seem to
lead to favourable results, both for bereaved individuals
suffering from complicated grief and bereaved individuals
suffering from bereavement-related depression [9]. Given
that these bereavement interventions differ in nature and
clinical effectiveness, results of this study should not be
generalised to indicated interventions or treatment for
bereavement related disorders, which are usually admin-
istered by a therapist instead of a volunteer and clearly dif-
fer from selective interventions like the visiting service.
Main findings
The experimental group demonstrated a small improve-
ment in health-related quality of life after the interven-
tion. This improvement was absent in the control group.
However, since the baseline scores in the control group
were significantly higher, there was less possibility for
improvement, and when we controlled for this 'false start'
the differences in effects on health-related quality of life
were no longer significant, which should be read as a
warning against overly optimistic interpretations of our
data. In both groups, the total costs were higher at the 12
months follow-up assessment than at baseline and the
additional costs were somewhat higher in the experimen-
tal group than in the control group, although the differ-
ence was not significant. Overall, the experimental group
demonstrated slightly better results against slightly higher
costs. Whether the visiting service is acceptable depends
on the willingness to pay: at a willingness to pay equal to
zero, the visiting service has a probability of 31% of being
acceptable; beyond €20,000, the visiting service has a
probability of 70% of being acceptable.
Limitations
We have to place these findings in the context of the lim-
itations of our study. There are several factors that limit
the generalizability of our findings. First, this study is con-
ducted alongside a randomized clinical trial on a visiting
service for older widowed individuals with sufficient
power to detect changes in clinical outcomes. However,
the study was underpowered to detect changes in costs,
which usually have large standard errors. Therefore, we
took a probabilistic course indicating the likelihood that
the intervention was superior from a health economic
point of view. The second limitation is the high initial
non-response. Only 11.4% of the approached widows
and widowers returned the informed consent form.
Although part of the non-response is caused by individu-Page 10 of 12
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from full-blown psychiatric disorders and by individuals
without feelings of loneliness, it is unlikely that this
applies for the complete non-response. Given the absence
of information on those widows and widowers not partic-
ipating in the study, the representativeness of the sample
is not clear. One of the risks of studying a vulnerable pop-
ulation is self-selection of the least vulnerable individuals.
The results of this study indicate that this probably also
applies to a certain extent to our sample. Although the
average utility score of our sample was significantly lower
at baseline (mean = 0.79; s.d. = 0.22) than the average
utility score of the general population (0.88), the average
baseline score of our sample did not correspond to high
distress either. Furthermore, our data were not complete.
At the 12 month follow-up assessment, 14.4% of the data
was missing. Although a loss to follow-up of 14% is not
much, considering the period of 1 year, the imputation of
missing values could still have distorted the results. How-
ever, completers did not differ from non-completers on
any of the baseline variables, which suggested that loss to
follow-up was completely at random. Another limitation
was the difference at baseline between the visiting service
group and the control group. Despite random allocation
to the research conditions, respondents of the visiting
service group were more lonely (mean loneliness score
was 7.1 (s.d. = 3.0) in the experimental group compared
to 6.0 (s.d. = 2.9) in the control condition; t = -2.66 and p
= 0.008) and had a worse quality of life (mean 0.76 QALY
(s.d. = 0.25) in the experimental group compared to 0.83
QALY (s.d. = 0.18) in the control condition; t = 2.19 and
p = 0.030). Although we controlled for both confounding
variables in our analyses, our results could have been
biased. In addition, instead of monitoring health care uti-
lisation over the entire year of interest in our study, which
would clearly imply a large burden on the respondents,
we made the simplifying assumption that the health care
utilisation during the 4 week period that was assessed
with the TIC-P could be interpolated to 1-year estimates
from the baseline and follow-up measures. Although we
expect that potential bias in these estimates are of similar
magnitude in both trial conditions and therefore cancel
each other out, the changes in health care costs over time
are presumably more complex than is assumed under our
model. Because of these limitations, the results of this
study should be considered with caution.
Conclusion
Despite its limitations, this study still offers new informa-
tion on the potential benefits of bereavement interven-
tions by (trained) volunteers. This study indicates that
even in the absence of clinical effectiveness of a bereave-
ment intervention its cost-effectiveness could still be
acceptable. However, the acceptability of the visiting serv-
ice we evaluated, depended mainly on the willingness to
pay. Beyond a willingness to pay of €8,000, the visiting
service has a probability of 50% of being more cost-effec-
tive than the control condition. At lower levels of willing-
ness to pay it is more likely that the visiting service is not
cost-effective than that the visiting service is superior.
We assumed that bereavement interventions could be
cost-effective because widows and widowers that have
been offered targeted support by volunteers will make less
use of health care services, the latter being considerably
more expensive than the attention of (trained) volunteers.
Our data suggests that widowed individuals in the experi-
mental group did indeed make less use of health care serv-
ices. In the experimental group, total costs without the
intervention costs decreased while costs in the control
group increased. However, these savings were not large
enough to compensate for the intervention costs. In this
study, the intervention was still more expensive overall
than the control condition.
We already know that bereavement interventions like the
visiting service do not produce large benefits in terms of
public mental health when targeted towards the entire
population of all widowed individuals [[8,9], Onrust et
al., submitted]. Based on this cost-utility analysis we can
now add that bereavement interventions like the visiting
service will also not produce large benefits from the health
economic point of view, when targeted towards the entire
population of all widowed individuals. Presumably, those
widowed individuals that are able to adjust relatively well
over time and do not need a specific intervention to regain
pre-bereavement levels of functioning, do not make fre-
quent use of the health care services related to their
bereavement as well. In light of our findings, we recom-
mend that in depth analyses are conducted to identify
who benefits most from this kind of interventions, and in
what subgroups the incremental cost-utility is best. In the
future bereavement interventions are then best directed to
these groups.
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